N-(2-Methyl-5-nitrophenyl) -4-(pyridin-3-yl) pyrimidin-2-amine CAS 152460-09-8 Imatinib Mesylate Intermedia High Munditia
Commercial Supple Imatinib Mesylate et intermedia:
Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl) -4-(pyridin-3-yl) pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS:
4-[(4-Methylpiperazin-1-yl) methyl] acidum benzoicum dihydrochloridum CAS: 106261-49-8
| Nomen chemicum | N-(2-Methyl-5-nitrophenyl) -4-(pyridin-3-yl) pyrimidin-2-amine |
| Synonyma | Imatinib Mesylate Intermedia;2-(2-Methyl-5-nitroanilino) -4-(3-pyridyl) pyrimidine |
| CAS Number | 152460-09-8 |
| CATTUS Number | RF-PI228 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C16H13N5O2 |
| M. Pondus | 307.31 |
| Liquescens punctum | 188.0~ 193.0℃ |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Flavo vel fere flavo pulverem |
| Puritas | ≥98.0% (HPLC) |
| Humor (KF) | ≤0.50% |
| Totalis immunditias | ≤2.0% |
| Maximum Impuritas | ≤1.0% |
| Requiesce in ignitio | ≤0.50% |
| Metalla gravis | ≤20ppm |
| Test Standard | Enterprise Standard |
| Consuetudinem | Imatinib Mesylate (CAS: 220127-57-1) |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
Shanghai Ruifu Chemical Co., Ltd. est praecipuum fabricam et supplementum N-(2-Methyl-5-nitrophenyl) -4-(pyridin-3-yl) pyrimidin-2-amine (CAS: 152460-09-8) magna qualitas.Medium proprie est in synthesi Imatinib Mesylate (CAS: 220127-57-1).
Imatinib Mesylate molecula parva est quae kinasem interdum tyrosinum c-Abl inhibet, valde specificum pro BCR-ABL, enzyme cum myelogenois leukemia chronicis (CML) et quibusdam formis lymphoblasticis leukemia acutis (ALL).Eventus translocatio inter chromosomatum 9 et 22 chromosomatum Philadelphiae gignit, quod deinde fusionem interdum Bcr-Abl producit cum actione kinasi aberrantis quae celerem cellulam multiplicationem promovet.Imatinib Mesylate hanc kinasem crucialem alligat, claudicans CML incrementum affinis.Imatinib Mesylate inhibere PDGFR et kinases tyrosinas cum c-Kit ulterius monstratum est.Formulae Imatinib mesylate continentur adhibitae in curatione carcinomata varia.
![4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici CAS 106261-49-8 Imatinib Mesylate intermedia High Munditia](https://www.ruifuchemical.com/uploads/d1fa2a19-300x300.jpg)